Rafael holdings appoints three highly experienced biopharmaceutical leaders to its board of directors

Newark, n.j., june 14, 2021 /prnewswire/ -- rafael holdings, inc., (nyse: rfl), a pharmaceutical company focused on developing novel cancer metabolism therapeutics, today announced the appointment of three senior biopharmaceutical leaders to its board of directors: ameet mallik, chief executive officer of rafael holdings; shannon thyme klinger, chief legal officer of moderna, inc., (nasdaq gs: mrna); and mark mccamish, m.d.
RFL Ratings Summary
RFL Quant Ranking